References
Key articles
Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 suppl 2):S102-38.Full text Abstract
Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-62.Full text Abstract
Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016 Jul;22 Suppl 3:1-203.Full text Abstract
National Institute for Health and Care Excellence. Obesity: identification, assessment and management. September 2022 [internet publication].Full text
American Society for Metabolic and Bariatric Surgery. Metabolic and bariatric surgery fact sheet. July 2021 [internet publication].Full text
Reference articles
1. Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 suppl 2):S102-38.Full text Abstract
2. World Health Organization. WHO discussion paper: draft recommendations for the prevention and management of obesity over the life course, including potential targets. August 2021 [internet publication].Full text
3. Kopelman PG. Obesity as a medical problem. Nature. 2000 Apr 6;404(6778):635-43. Abstract
4. Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011 Apr 19;123(15):1683-701.Full text Abstract
5. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva, Switzerland: World Health Organization; 2000.Full text
6. Centers for Disease Control and Prevention. Defining adult overweight and obesity. June 2022 [internet publication].Full text
7. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002 Oct 14;162(18):2074-9.Full text Abstract
8. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994 Mar 1;73(7):460-8. Abstract
9. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005 Sep 24-30;366(9491):1059-62. Abstract
10. Booth ML, Hunter C, Gore CJ, et al. The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight. Int J Obes Relat Metab Disord. 2000 Aug;24(8):1058-61. Abstract
11. Centers for Disease Control and Prevention: National Center for Health Statistics. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. January 2021 [internet publication].Full text
12. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002 Nov;66(11):987-92.Full text Abstract
13. Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr. 2021 Jun 30;30(2):81-92.Full text Abstract
14. World Health Organization. Obesity and overweight. Fact sheets. June 2021 [internet publication].Full text
15. World Health Organization. Health topics: obesity [internet publication].Full text
16. Comuzzie AG, Allison DB. The search for human obesity genes. Science. 1998 May 29;280(5368):1374-7. Abstract
17. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005 Mar;6(3):221-34. Abstract
18. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am. 2003 Dec;32(4):895-914. Abstract
19. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997 Jun 26;387(6636):903-8. Abstract
20. Ello-Martin JA, Ledikwe JH, Rolls BJ. The influence of food portion size and energy density on energy intake: implications for weight management. Am J Clin Nutr. 2005 Jul;82(1 suppl):236-41S.Full text Abstract
21. Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA. 2003 Jan 22-29;289(4):450-3.Full text Abstract
22. Young LR, Nestle M. The contribution of expanding portion sizes to the US obesity epidemic. Am J Public Health. 2002 Feb;92(2):246-9.Full text Abstract
23. Hu FB, Li TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003 Apr 9;289(14):1785-91.Full text Abstract
24. Manson JE, Skerrett PJ, Greenland P, et al. The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med. 2004 Feb 9;164(3):249-58. Abstract
25. Dreon DM, Frey-Hewitt B, Ellsworth N, et al. Dietary fat:carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr. 1988 Jun;47(6):995-1000. Abstract
26. Wamala SP, Wolk A, Orth-Gomer K. Determinants of obesity in relation to socioeconomic status among middle-aged Swedish women. Prev Med. 1997 Sep-Oct;26(5 Pt 1):734-44. Abstract
27. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Feb;160(2):255-61.Full text Abstract
28. Fairburn CG, Harrison PJ. Eating disorders.Lancet. 2003 Feb 1;361(9355):407-16. Abstract
29. Megna JL, Schwartz TL, Siddiqui UA, et al. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. Ann Clin Psychiatry. 2011 May;23(2):131-40. Abstract
30. Hazuda HP, Haffner SM, Stern MP, et al. Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol. 1988 Dec;128(6):1289-301. Abstract
31. Kumanyika SK. Special issues regarding obesity in minority populations. Ann Intern Med. 1993 Oct 1;119(7):650-4. Abstract
32. Martinez JA, Kearney JM, Kafatos A, et al. Variables independently associated with self-reported obesity in the European Union. Public Health Nutr. 1999 Mar;2(1A):125-33. Abstract
33. Parsons TJ, Power C, Logan S, et al. Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord. 1999 Nov;23(suppl 8):S1-107. Abstract
34. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997 Sep 25;337(13):869-73.Full text Abstract
35. Mokhtar N, Elati J, Chabir R, et al. Diet culture and obesity in northern Africa. J Nutr. 2001 Mar;131(3):887-92S.Full text Abstract
36. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523-9.Full text Abstract
37. Swinburn B, Egger G, Raza F. Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med. 1999 Dec;29(6):563-70. Abstract
38. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1-5. Abstract
39. Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr. 2004 Jan;79(1):6-16.Full text Abstract
40. Sobal J, Stunkard AJ. Socioeconomic status and obesity: a review of the literature. Psychol Bull. 1989 Mar;105(2):260-75. Abstract
41. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976 Aug 12;295(7):349-53. Abstract
42. Curhan GC, Willett WC, Rimm EB, et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996 Dec 15;94(12):3246-50.Full text Abstract
43. Maruvada P, Leone V, Kaplan LM, et al. The human microbiome and obesity: moving beyond associations. Cell Host Microbe. 2017 Nov 8;22(5):589-99.Full text Abstract
44. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998 Sep;102(3):E29. Abstract
45. Finlayson G, King N, Blundell JE. Liking vs. wanting food: Importance for human appetite control and weight regulation. Neurosci Biobehav Rev. 2007;31(7):987-1002. Abstract
46. Dhillo WS. Appetite regulation: an overview. Thyroid. 2007 May;17(5):433-45. Abstract
47. Campbell JE. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms. Mol Metab. 2021 Apr;46:101139.Full text Abstract
48. Nauck MA, Quast DR, Wefers J, et al. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update. Diabetes Obes Metab. 2021 Sep;23 Suppl 3:5-29.Full text Abstract
49. Blüher M. Metabolically healthy obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.Full text Abstract
50. Commodore-Mensah Y, Lazo M, Tang O, et al. High burden of subclinical and cardiovascular disease risk in adults with metabolically healthy obesity: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2021 Jul;44(7):1657-63. Abstract
51. Opio J, Croker E, Odongo GS, et al. Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: a systematic review and meta-analysis of prospective cohort studies. Obes Rev. 2020 Dec;21(12):e13127. Abstract
52. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 Apr 5;295(13):1549-55.Full text Abstract
53. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999 Oct 27;282(16):1519-22.Full text Abstract
54. Astrup A. Physical activity and weight gain and fat distribution changes with menopause: current evidence and research issues. Med Sci Sports Exerc. 1999 Nov;31(11 suppl):S564-7. Abstract
55. Kongnyuy EJ, Norman RJ, Flight IH, et al. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev. 2000;(2):CD001018.Full text Abstract
56. Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997 Feb;82(2):414-7.Full text Abstract
57. Rossner S, Ohlin A. Pregnancy as a risk factor for obesity: lessons from the Stockholm Pregnancy and Weight Development Study. Obes Res. 1995;3(suppl 2):S267-75. Abstract
58. Schmitt NM, Nicholson WK, Schmitt J. The association of pregnancy and the development of obesity - results of a systematic review and meta-analysis on the natural history of postpartum weight retention. Int J Obes (Lond). 2007 Nov;31(11):1642-51. Abstract
59. Kahn HS, Williamson DF, Stevens JA. Race and weight change in US women: the roles of socioeconomic and marital status. Am J Public Health. 1991 Mar;81(3):319-23.Full text Abstract
60. Schoenborn CA. Marital status and health: United States, 1999-2002. Adv Data. 2004 Dec 15;(351):1-32.Full text Abstract
61. Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep. 2004 Jun 15;27(4):661-6. Abstract
62. Vioque J, Torres A, Quiles J. Time spent watching television, sleep duration and obesity in adults living in Valencia, Spain. Int J Obes Relat Metab Disord. 2000 Dec;24(12):1683-8. Abstract
63. Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005 Oct;28(10):1289-96. Abstract
64. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003 Jan 7;138(1):24-32. Abstract
65. O'Hara P, Connett JE, Lee WW, et al. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol. 1998 Nov 1;148(9):821-30.Full text Abstract
66. Molarius A, Seidell JC, Sans S, et al. Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health. 2000 Aug;90(8):1260-8.Full text Abstract
67. Drewnowski A, Darmon N. The economics of obesity: dietary energy density and energy cost. Am J Clin Nutr. 2005 Jul;82(1 suppl):265-73S.Full text Abstract
68. Wareham NJ, van Sluijs EM, Ekelund U. Physical activity and obesity prevention: a review of the current evidence. Proc Nutr Soc. 2005 May;64(2):229-47. Abstract
69. Tremblay MS, Willms JD. Is the Canadian childhood obesity epidemic related to physical inactivity? Int J Obes Relat Metab Disord. 2003 Sep;27(9):1100-5. Abstract
70. Ludwig DS. Dietary glycemic index and obesity. J Nutr. 2000 Feb;130(2S suppl):280-3S.Full text Abstract
71. Das SK, Gilhooly CH, Golden JK, et al. Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr. 2007 Apr;85(4):1023-30.Full text Abstract
72. Ebbeling CB, Leidig MM, Feldman HA, et al. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA. 2007 May 16;297(19):2092-102.Full text Abstract
73. Colditz GA, Giovannucci E, Rimm EB, et al. Alcohol intake in relation to diet and obesity in women and men. Am J Clin Nutr. 1991 Jul;54(1):49-55. Abstract
74. Arif AA, Rohrer JE. Patterns of alcohol drinking and its association with obesity: data from the Third National Health and Nutrition Examination Survey, 1988-1994. BMC Public Health. 2005 Dec 5;5:126.Full text Abstract
75. Greenfield JR, Samaras K, Jenkins AB, et al. Moderate alcohol consumption, dietary fat composition, and abdominal obesity in women: evidence for gene-environment interaction. J Clin Endocrinol Metab. 2003 Nov;88(11):5381-6.Full text Abstract
76. Chou SY, Grossman M, Saffer H. An economic analysis of adult obesity: results from the Behavioral Risk Factor Surveillance System. J Health Econ. 2004 May;23(3):565-87. Abstract
77. Wing RR, Goldstein MG, Acton KJ, et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care. 2001 Jan;24(1):117-23.Full text Abstract
78. Gluck ME, Geliebter A, Satov T. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients. Obes Res. 2001 Apr;9(4):264-7. Abstract
79. Colles SL, Dixon JB, O'Brien PE. Night eating syndrome and nocturnal snacking: association with obesity, binge eating and psychological distress. Int J Obes (Lond). 2007 Nov;31(11):1722-30. Abstract
80. Zimmermann U, Kraus T, Himmerich H, et al. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res. 2003 May-Jun;37(3):193-220. Abstract
81. McCloughen A, Foster K. Weight gain associated with taking psychotropic medication: an integrative review. Int J Ment Health Nurs. 2011 Jun;20(3):202-22. Abstract
82. Sharma AM, Pischon T, Hardt S, et al. Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension. 2001 Feb;37(2):250-4.Full text Abstract
83. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001 Jun 28;344(26):1997-2008. Abstract
84. Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006 Jul;63(7):824-30.Full text Abstract
85. Allison DB, Fontaine KR, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry. 1999 Apr;60(4):215-20. Abstract
86. Van Horn L, Carson JA, Appel LJ, et al. Recommended dietary pattern to achieve adherence to the American Heart Association/American College of Cardiology (AHA/ACC) guidelines: a scientific statement from the American Heart Association. Circulation. 2016 Nov 29;134(22):e505-29.Full text Abstract
87. US Department of Health and Human Services; US Department of Agriculture. Dietary guidelines for Americans 2020-2025. 9th edition. December 2020 [internet publication].Full text
88. Swinburn BA, Caterson I, Seidell JC, et al. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004 Feb;7(1a):123-46. Abstract
89. Kirk SF, Penney TL, McHugh TL. Characterizing the obesogenic environment: the state of the evidence with directions for future research. Obes Rev. 2010 Feb;11(2):109-17. Abstract
90. Kwon J, Cameron AJ, Hammond D, et al. A multi-country survey of public support for food policies to promote healthy diets: findings from the International Food Policy Study. BMC Public Health. 2019 Sep 2;19(1):1205.Full text Abstract
91. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-62.Full text Abstract
92. Heyword VH, Wagner DR. Applied body composition assessment. 2nd ed. Champaign, IL: Human Kinetics; 2004.
93. World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation. 2011 [internet publication].Full text
94. Herbst KL, Kahn LA, Iker E, et al. Standard of care for lipedema in the United States. Phlebology. 2021 Dec;36(10):779-96.Full text Abstract
95. Buso G, Depairon M, Tomson D, et al. Lipedema: a call to action! Obesity (Silver Spring). 2019 Oct;27(10):1567-76.Full text Abstract
96. Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Sep 4;157(5):373-8.Full text Abstract
97. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016 Jul;22 Suppl 3:1-203.Full text Abstract
98. Brauer P, Gorber SC, Shaw E, et al. Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ. 2015 Feb 17;187(3):184-95.Full text Abstract
99. National Institute for Health and Care Excellence. Obesity: identification, assessment and management. September 2022 [internet publication].Full text
100. Rosenzweig JL, Bakris GL, Berglund LF, et al. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019 Sep;104(9):3939-85.Full text Abstract
101. Khan LK, Sobush K, Keener D, et al; Centers for Disease Control and Prevention. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep. 2009 Jul 24;58(RR-7):1-26.Full text Abstract
102. Shaw K, Gennat H, O'Rourke P, et al. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003817.Full text Abstract
103. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007 Oct;107(10):1755-67. Abstract
104. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009 Feb 26;360(9):859-73.Full text Abstract
105. Shai I, Schwarzfuchs D, Henkin Y, et al; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41.Full text Abstract
106. Hession M, Rolland C, Kulkarni U, et al. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev. 2009 Jan;10(1):36-50.Full text Abstract
107. Thomas DE, Elliott E, Baur L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005105.Full text Abstract
108. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003 May 22;348(21):2074-81.Full text Abstract
109. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003 May 22;348(21):2082-90.Full text Abstract
110. Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015 Apr 7;162(7):501-12.Full text Abstract
111. Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014 Sep 3;312(9):923-33.Full text Abstract
112. Ge L, Sadeghirad B, Ball GDC, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020 Apr 1;369:m696.Full text Abstract
113. Wu T, Gao X, Chen M, et al. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev. 2009 May;10(3):313-23.Full text Abstract
114. Semlitsch T, Stigler FL, Jeitler K, et al. Management of overweight and obesity in primary care - a systematic overview of international evidence-based guidelines. Obes Rev. 2019 Sep;20(9):1218-30.Full text Abstract
115. Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018 Nov 20;320(19):2020-8. Abstract
116. Booth HP, Prevost TA, Wright AJ, et al. Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract. 2014 Dec;31(6):643-53.Full text Abstract
117. Södlerlund A, Fischer A, Johansson T. Physical activity, diet and behaviour modification in the treatment of overweight and obese adults: a systematic review. Perspect Public Health. 2009 May;129(3):132-42. Abstract
118. Curry SJ, Krist AH, Owens DK, et al; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018 Sep 18;320(11):1163-71.Full text Abstract
119. Castelnuovo G, Pietrabissa G, Manzoni GM, et al. Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives. Psychol Res Behav Manag. 2017;10:165-73.Full text Abstract
120. Svetkey LP, Stevens VJ, Brantley PJ, et al; Weight Loss Maintenance Collaborative Research Group. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008 Mar 12;299(10):1139-48.Full text Abstract
121. Vanwormer JJ, French SA, Pereira MA, et al. The impact of regular self-weighing on weight management: a systematic literature review. Int J Behav Nutr Phys Act. 2008 Nov 4;5:54.Full text Abstract
122. Manzoni GM, Pagnini F, Corti S, et al. Internet-based behavioral interventions for obesity: an updated systematic review. Clin Pract Epidemiol Ment Health. 2011 Mar 4;7:19-28.Full text Abstract
123. Maon S, Edirippulige S, Ware R, et al. The use of web-based interventions to prevent excessive weight gain. J Telemed Telecare. 2012 Jan;18(1):37-41. Abstract
124. Crane MM, Lutes LD, Ward DS, et al. A randomized trial testing the efficacy of a novel approach to weight loss among men with overweight and obesity. Obesity (Silver Spring). 2015 Dec;23(12):2398-405.Full text Abstract
125. Chen J, Cade JE, Allman-Farinelli M. The most popular smartphone apps for weight loss: a quality assessment. JMIR Mhealth Uhealth. 2015 Dec 16;3(4):e104.Full text Abstract
126. Carey A, Yang Q, DeLuca L, et al. The relationship between weight loss outcomes and engagement in a mobile behavioral change intervention: retrospective analysis. JMIR Mhealth Uhealth. 2021 Nov 8;9(11):e30622.Full text Abstract
127. Petkovic J, Duench S, Trawin J, et al. Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population. Cochrane Database Syst Rev. 2021 May 31;5:CD012932.Full text Abstract
128. Baer HJ, Rozenblum R, De La Cruz BA, et al. Effect of an online weight management program integrated with population health management on weight change: a randomized clinical trial. JAMA. 2020 Nov 3;324(17):1737-46.Full text Abstract
129. Grunvald E, Shah R, Hernaez R, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022 Nov;163(5):1198-1225.Full text Abstract
130. Bergmann NC, Davies MJ, Lingvay I, et al. Semaglutide for the treatment of overweight and obesity: a review. Diabetes Obes Metab. 2023 Jan;25(1):18-35.Full text Abstract
131. Yanovski SZ, Yanovski JA. Progress in pharmacotherapy for obesity. JAMA. 2021 Jul 13;326(2):129-30. Abstract
132. Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021 Apr 13;325(14):1414-25.Full text Abstract
133. Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021 Apr 13;325(14):1403-13.Full text Abstract
134. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023 Dec 14;389(24):2221-32. Abstract
135. Ida S, Kaneko R, Imataka K, et al. Effects of antidiabetic drugs on muscle mass in type 2 diabetes mellitus. Curr Diabetes Rev. 2021;17(3):293-303. Abstract
136. Isaacs D, Prasad-Reddy L, Srivastava SB. Role of glucagon-like peptide 1 receptor agonists in management of obesity. Am J Health Syst Pharm. 2016 Oct 1;73(19):1493-507. Abstract
137. Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA. 2015 Aug 18;314(7):687-99. Abstract
138. Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015 Jul 2;373(1):11-22.Full text Abstract
139. Lundgren JR, Janus C, Jensen SBK, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021 May 6;384(18):1719-30.Full text Abstract
140. Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes (Lond). 2013 Nov;37(11):1443-51. Abstract
141. Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022 Jan 11;327(2):138-50. Abstract
142. Wadden TA, Chao AM, Machineni S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nat Med. 2023 Nov;29(11):2909-18.Full text Abstract
143. Abbasi J. FDA Green-Lights Tirzepatide, Marketed as Zepbound, for chronic weight management. JAMA. 2023 Dec 12;330(22):2143-4.Full text Abstract
144. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022 Jul 21;387(3):205-16.Full text Abstract
145. Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021 Jul 10;398(10295):143-55. Abstract
146. Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016 Jun 14;315(22):2424-34.Full text Abstract
147. Derosa G, Maffioli P, Ferrari I, et al. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J. 2010;57(9):777-86.Full text Abstract
148. Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010 Aug 21;376(9741):595-605. Abstract
149. Greenway FL, Dunayevich E, Tollefson G, et al. Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metab. 2009 Dec;94(12):4898-906. Abstract
150. Apovian CM, Aronne L, Rubino D, et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May;21(5):935-43.Full text Abstract
151. Wadden TA, Foreyt JP, Foster GD, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan;19(1):110-20.Full text Abstract
152. Hollander P, Gupta AK, Plodkowski R, et al; COR-Diabetes Study Group. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013 Dec;36(12):4022-9.Full text Abstract
153. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011 Apr 16;377(9774):1341-52. Abstract
154. Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012 Feb;20(2):330-42.Full text Abstract
155. Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb;95(2):297-308.Full text Abstract
156. Lei XG, Ruan JQ, Lai C, et al. Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: a systematic review and meta-analysis. Obesity (Silver Spring). 2021 Jun;29(6):985-94. Abstract
157. Markham A. Setmelanotide: first approval. Drugs. 2021 Feb;81(3):397-403. Abstract
158. National Institute for Health and Care Excellence. Setmelanotide for treating obesity caused by LEPR or POMC deficiency [HST21]. July 2022 [internet publication].Full text
159. Clément K, van den Akker E, Argente J, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-70. Abstract
160. Haqq AM, Chung WK, Dollfus H, et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-68. Abstract
161. Food and Drug Adminstration. FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. February 2020 [internet publication].Full text
162. Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020 Sep 1;324(9):879-87. Abstract
163. Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Metabolic and endocrine consequences of bariatric surgery. Front Endocrinol (Lausanne). 2019 Sep 19;10:626.Full text Abstract
164. Osorio-Conles Ó, Vidal J, de Hollanda A. Impact of bariatric surgery on adipose tissue biology. J Clin Med. 2021 Nov 25;10(23):5516.Full text Abstract
165. Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021 May 15;397(10287):1830-41. Abstract
166. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014 Aug 8;(8):CD003641.Full text Abstract
167. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248-56. Abstract
168. Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009 Sep 28;169(17):1619-26.Full text Abstract
169. American Society for Metabolic and Bariatric Surgery. Metabolic and bariatric surgery fact sheet. July 2021 [internet publication].Full text
170. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005 May-Jun;1(3):371-81. Abstract
171. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005 Apr 5;142(7):547-59.Full text Abstract
172. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023 Jan;33(1):3-14.Full text Abstract
173. Schauer PR, Bhatt DL, Kirwan JP, et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017 Feb 16;376(7):641-51.Full text Abstract
174. Berry MA, Urrutia L, Lamoza P, et al. Sleeve gastrectomy outcomes in patients with BMI between 30 and 35 - 3 years of follow-up. Obes Surg. 2018 Mar;28(3):649-55.Full text Abstract
175. Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016 Jan 12;315(2):150-63.Full text Abstract
176. Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008 Oct;121(10):885-93. Abstract
177. Garb J, Welch G, Zagarins S, et al. Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg. 2009 Oct;19(10):1447-55. Abstract
178. Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009 Oct;250(4):631-41. Abstract
179. Risstad H, Søvik TT, Engström M, et al. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg. 2015 Apr;150(4):352-61. Abstract
180. ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012 May-Jun;8(3):e21-6. Abstract
181. Ben-Porat T, Mashin L, Kaluti D, et al. Weight loss outcomes and lifestyle patterns following sleeve gastrectomy: an 8-year retrospective sStudy of 212 patients. Obes Surg. 2021 Nov;31(11):4836-45. Abstract
182. O'Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes afteradjustable gastric banding. Obes Surg. 2019 Jan;29(1):3-14.Full text Abstract
183. Sepúlveda M, Alamo M, Saba J, et al. Long-term weight loss in laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2017 Oct;13(10):1676-81. Abstract
184. Felsenreich DM, Langer FB, Kefurt R, et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016 Nov;12(9):1655-62. Abstract
185. Fernandes M, Atallah AN, Soares BG, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004931.Full text Abstract
186. Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity: a meta-analysis. Obes Surg. 2008 Jul;18(7):841-6. Abstract
187. Muniraj T, Day LW, Teigen LM, et al. AGA clinical practice guidelines on intragastric balloons in the management of obesity. Gastroenterology. 2021 Apr;160(5):1799-808.Full text Abstract
188. Gleysteen JJ. A history of intragastric balloons. Surg Obes Relat Dis. 2016 Feb;12(2):430-5. Abstract
189. Gibbons C, Blundell J, Tetens Hoff S, et al. Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes. Diabetes Obes Metab. 2021 Feb;23(2):581-8.Full text Abstract
190. Smith SR, Aronne LJ, Burns CM, et al. Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care. 2008 Sep;31(9):1816-23.Full text Abstract
191. Dunican KC, Adams NM, Desilets AR. The role of pramlintide for weight loss. Ann Pharmacother. 2010 Mar;44(3):538-45. Abstract
192. Enebo LB, Berthelsen KK, Kankam M, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021 May 8;397(10286):1736-48. Abstract
193. Després JP, Ross R, Boka G, et al; ADAGIO-Lipids Investigators. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):416-23.Full text Abstract
194. Chavez-Tapia NC, Tellez-Avila FI, Bedogni G, et al. Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. BMC Gastroenterol. 2009 Oct 9;9:75.Full text Abstract
195. Topol EJ, Bousser MG, Fox KA, et al. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet. 2010 Aug 14;376(9740):517-23. Abstract
196. Quarta C, Cota D. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice. Int J Obes (Lond). 2020 Nov;44(11):2179-93. Abstract
197. Mekala KC, Tritos NA. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. J Clin Endocrinol Metab. 2009 Jan;94(1):130-7.Full text Abstract
198. Liang S, Xue J, Li G. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency. Lipids Health Dis. 2018 Apr 3;17(1):66.Full text Abstract
199. Wu J, Zhao F, Zhang Y, et al. Effect of one-year growth hormone therapy on cardiometabolic risk factors in boys with obesity. Biomed Res Int. 2020;2020:2308124.Full text Abstract
200. Kaptein EM, Beale E, Chan LS. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 2009 Oct;94(10):3663-75. Abstract
201. Kopelman P, Bryson A, Hickling R, et al. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes (Lond). 2007 Mar;31(3):494-9. Abstract
202. Kopelman P, Groot Gde H, Rissanen A, et al. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). Obesity (Silver Spring). 2010 Jan;18(1):108-15. Abstract
203. Pu R, Shi D, Gan T, et al. Effects of metformin in obesity treatment in different populations: a meta-analysis. Ther Adv Endocrinol Metab. 2020;11:2042018820926000.Full text Abstract
204. Astrup A, Madsbad S, Breum L, et al. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Nov 29;372(9653):1906-13. Abstract
205. Ikramuddin S, Blackstone RP, Brancatisano A, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA. 2014 Sep 3;312(9):915-22.Full text Abstract
206. Shikora S, Toouli J, Herrera MF, et al. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013;2013:245683.Full text Abstract
207. Sarr MG, Billington CJ, Brancatisano R, et al. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg. 2012 Nov;22(11):1771-82. Abstract
208. Koehestanie P, de Jonge C, Berends FJ, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg. 2014 Dec;260(6):984-92. Abstract
209. Ruban A, Miras AD, Glaysher MA, et al. Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity: a multicenter randomized controlled trial. Ann Surg. 2022 Mar 1;275(3):440-7.Full text Abstract
210. Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg. 2018 Jul;28(7):1812-21. Abstract
211. Jalal MA, Cheng Q, Edye MB. Systematic review and meta-analysis of endoscopic sleeve gastroplasty with comparison to laparoscopic sleeve gastrectomy. Obes Surg. 2020 Jul;30(7):2754-62. Abstract
212. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 May 25;143(21):e984-e1010.Full text Abstract
213. Campos GM, Mazzini GS, Altieri MS, et al. ASMBS position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery. Surg Obes Relat Dis. 2021 May;17(5):837-47. Abstract
214. Mechanick JI, Apovian C, Brethauer S, et al; American Association of Clinical Endocrinologists. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update. Surg Obes Relat Dis. 2020 Feb;16(2):175-247. Abstract
215. Telem DA, Jones DB, Schauer PR, et al. Updated panel report: best practices for the surgical treatment of obesity. Surg Endosc. 2018 Oct;32(10):4158-64. Abstract
216. Aminian A, Chang J, Brethauer SA, et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m^2). Surg Obes Relat Dis. 2018 Aug;14(8):1071-87.Full text Abstract
217. US Department of Health and Human Services. Physical activity guidelines for Americans. 2nd edition. 2018 [internet publication].Full text
218. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015 Feb;100(2):342-62.Full text Abstract
219. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Jun 2019 [internet publication].Full text
220. Cohen RV, Shikora S, Petry T, et al. The Diabetes Surgery Summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016 Aug;26(8):1989-91. Abstract
221. Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res. 2004 Dec;12(suppl):151-62S.Full text Abstract
222. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007 May;132(6):2226-38. Abstract
223. Blaine BE, Rodman J, Newman JM. Weight loss treatment and psychological well-being: a review and meta-analysis. J Health Psychol. 2007 Jan;12(1):66-82. Abstract
224. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007 Jan 6;369(9555):71-7. Abstract
225. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-64.Full text Abstract
226. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007 Oct;142(4):621-32. Abstract
227. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007 May 24;356(21):2176-83. Abstract
228. Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007 Feb;17(2):168-75. Abstract
229. Sjöström L, Lindroos AK, Peltonen M, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 Dec 23;351(26):2683-93.Full text Abstract
230. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity: the future procedure of choice? Surg Today. 2007;37(4):275-81. Abstract
231. Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Obes Surg. 2010 Aug;20(8):1171-7. Abstract
232. Shi X, Karmali S, Sharma AM, et al. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010 Aug;20(8):1171-7. Abstract
233. Sarkhosh K, Birch DW, Shi X, et al. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg. 2012 May;22(5):832-7. Abstract
234. Frantzides CT, Alexander B, Frantzides AT. Laparoscopic revision of failed bariatric procedures. JSLS. 2019 Jan-Mar;23(1):e2018.00074.Full text Abstract
235. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007 May;17(4):319-26. Abstract
236. Donahue RP, Abbott RD, Bloom E, et al. Central obesity and coronary heart disease in men. Lancet. 1987 Apr 11;1(8537):821-4. Abstract
237. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998 Dec 2;280(21):1843-8.Full text Abstract
238. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990 Mar 29;322(13):882-9.Full text Abstract
239. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006 Aug 19;368(9536):666-78. Abstract
240. Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA. 2004 Sep 8;292(10):1179-87.Full text Abstract
241. Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007 May;132(6):2087-102. Abstract
242. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993 Oct 1;119(7):655-60. Abstract
243. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003 Jan 1;289(1):76-9.Full text Abstract
244. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985 Dec;103(6):983-8. Abstract
245. Wilson JB, Pories WJ. Durable remission of diabetes after bariatric surgery: what is the underlying pathway? Insulin. 2010 Jan;5(1):46-55.
246. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987 Jan;36(1):54-9. Abstract
247. Williams DP, Going SB, Lohman TG, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. 1992 Mar;82(3):358-63.Full text Abstract
248. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004 Mar;79(3):379-84.Full text Abstract
249. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention, phase I. JAMA. 1992 Mar 4;267(9):1213-20. Abstract
250. Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005 Jan;45(1):9-14.Full text Abstract
251. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007340.Full text Abstract
252. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-91.Full text Abstract
253. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer--viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8.Full text Abstract
254. Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022 Jun 28;327(24):2423-33.Full text Abstract
255. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006 Aug 24;355(8):763-78.Full text Abstract
256. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005 Apr 20;293(15):1861-7.Full text Abstract
257. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45. Abstract
258. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999 Oct 7;341(15):1097-105.Full text Abstract
259. Yu E, Ley SH, Manson JE, et al. Weight history and all-cause and cause-specific mortality in three prospective cohort studies. Ann Intern Med. 2017 May 2;166(9):613-20. Abstract
260. Chen C, Ye Y, Zhang Y, et al. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ. 2019 Oct 16;367:l5584.Full text Abstract
261. Voegeli D. Intertrigo: causes, prevention and management. Br J Nurs. 2020 Jun 25;29(12):S16-S22. Abstract
262. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010 Jan;11(1):41-50. Abstract
263. Shekelle PG, Newberry S, Maglione M, et al. Bariatric surgery in women of reproductive age: special concerns for pregnancy. Evid Rep Technol Assess (Full Rep). 2008 Nov;(169):1-51. Abstract
264. McMahon MM, Sarr MG, Clark MM, et al. Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc. 2006 Oct;81(10 suppl):S34-45. Abstract
265. Frantzides CT, Carlson MA, Schulte WJ. Laparoscopic gastric bypass in a porcine model. J Laparoendosc Surg. 1995 Apr;5(2):97-100. Abstract
266. Agarwal R, Hecht TE, Lazo MC, et al. Venous thromboembolism prophylaxis for patients undergoing bariatric surgery: a systematic review. Surg Obes Relat Dis. 2010 Mar 4;6(2):213-20. Abstract
267. Frantzides CT, Welle SN, Ruff TM, et al. Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass. JSLS. 2012 Jan-Mar;16(1):33-7.Full text Abstract
268. Rajasekhar A, Crowther M. Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. J Thromb Haemost. 2010 Jun;8(6):1266-70.Full text Abstract
269. Frantzides CT, Carlson MA, Shostrom VK, et al. A survey of dumping symptomatology after gastric bypass with or without lesser omental transection. Obes Surg. 2011 Feb;21(2):186-93. Abstract
270. Brown T, Avenell A, Edmunds LD, et al. Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obes Rev. 2009 Nov;10(6):627-38. Abstract
271. Greaves C, Poltawski L, Garside R, et al. Understanding the challenge of weight loss maintenance: a systematic review and synthesis of qualitative research on weight loss maintenance. Health Psychol Rev. 2017 Jun;11(2):145-63. Abstract
Use of this content is subject to our disclaimer